Holst JJ - Search Results

1

Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals.

Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, Veedfald S, Stensen S, Lanng AR, Bergmann NC, Christensen MB, Vilsbøll T, Holst JJ, Rosenkilde MM, Knop FK. Gasbjerg LS, et al. Among authors: holst jj. Diabetes. 2019 May;68(5):906-917. doi: 10.2337/db18-1123. Epub 2019 Jan 9. Diabetes. 2019. PMID: 30626611 Clinical Trial.

2

Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man.

Busch-Sørensen M, Holst JJ, Lyngsøe J. Busch-Sørensen M, et al. Among authors: holst jj. J Endocrinol Invest. 1991 Jan;14(1):25-30. doi: 10.1007/BF03350253. J Endocrinol Invest. 1991. PMID: 1675225 Clinical Trial.

3

Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting.

Almdal TP, Holst JJ, Heindorff H, Vilstrup H. Almdal TP, et al. Among authors: holst jj. Diabetes. 1992 Jan;41(1):12-6. doi: 10.2337/diab.41.1.12. Diabetes. 1992. PMID: 1727732

4

Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.

Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Deacon CF, et al. Among authors: holst jj. Diabetes. 1995 Sep;44(9):1126-31. doi: 10.2337/diab.44.9.1126. Diabetes. 1995. PMID: 7657039

5

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.

Deacon CF, Johnsen AH, Holst JJ. Deacon CF, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1995 Mar;80(3):952-7. doi: 10.1210/jcem.80.3.7883856. J Clin Endocrinol Metab. 1995. PMID: 7883856

6

Proglucagon processing in porcine and human pancreas.

Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, Orskov C. Holst JJ, et al. J Biol Chem. 1994 Jul 22;269(29):18827-33. J Biol Chem. 1994. PMID: 8034635 Free article.

7

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.

Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ. Orskov C, et al. Among authors: holst jj. Diabetes. 1994 Apr;43(4):535-9. doi: 10.2337/diab.43.4.535. Diabetes. 1994. PMID: 8138058

8

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.

Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ. Hvidberg A, et al. Among authors: holst jj. Metabolism. 1994 Jan;43(1):104-8. doi: 10.1016/0026-0495(94)90164-3. Metabolism. 1994. PMID: 8289665

9

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable.

Orskov C, Wettergren A, Holst JJ. Orskov C, et al. Among authors: holst jj. Diabetes. 1993 May;42(5):658-61. doi: 10.2337/diab.42.5.658. Diabetes. 1993. PMID: 8482423

10

The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.

Toft-Nielson M, Madsbad S, Holst JJ. Toft-Nielson M, et al. Among authors: holst jj. Diabetes. 1996 May;45(5):552-6. doi: 10.2337/diab.45.5.552. Diabetes. 1996. PMID: 8621002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,777 results

Search Page

Filters